MRC1 and neoplasm: Apart from direct sequencing of the MMR genes or promoter methylation study, MMR defect is also indicated by MSI phenotype as detectable by PCR on paired tumor normal sample, NGS genomic profiling, or immunohistochemistry (IHC) study of MMR gene expression on tumor cells.